Revance, Velocity + MedPharmics, Arsenal, SpringWorks
A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesRevanceVelocity +…